-
A COST-CONSEQUENCE ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA IN THE UNITED ARAB EMIRATES
Aug 11, 2026, 17:15 PM -
EVALUATING THE SATISFACTION WITH LIFE SCALE ACROSS DIVERSE ROLES: A MULTI-GROUP INVARIANCE ANALYSIS OF STUDENTS, TEACHERS, MANAGERS, AND INDIVIDUALS WITH DISABILITIES FROM ONE COUNTRY
Aug 11, 2026, 17:15 PM -
IMPLEMENTATION FRAMEWORKS FOR AI-BASED HEALTH CARE INNOVATIONS: A SCOPING REVIEW
Aug 11, 2026, 17:15 PM -
HOW IMMATURE IS TOO IMMATURE? OS DATA TRENDS IN NICE HTA SUBMISSIONS
Aug 11, 2026, 17:15 PM -
ECONOMIC BURDEN OF PNEUMOCOCCAL DISEASE OVER 2019-2022 ACROSS RISK PROFILES IN ADULTS: A FRENCH NATIONAL CLAIMS DATABASE STUDY
Aug 11, 2026, 17:15 PM -
CLINICAL UNDER-RECOGNITION OF SEVERE HYPERTRIGLYCERIDEMIA PATIENTS IN REAL WORLD PRACTICE: INSIGHTS FROM ICD CODING AND TRIGLYCERIDE LEVELS
Aug 11, 2026, 17:15 PM -
VALIDATING PHARMACOECONOMIC MODELS BUILT USING THE MODELYNX GENERATIVE AI HEALTH-ECONOMIC MODELING APPLICATION
Aug 11, 2026, 17:15 PM -
DISTINGUISHING FAMILIAL CHYLOMICRONEMIA: DIAGNOSTIC PITFALLS AND CLINICAL IMPLICATIONS
Aug 11, 2026, 17:15 PM -
ECONOMIC IMPACT OF THE CONNECTED ICU: MOVING FROM REACTIVE TO PROACTIVE HEALTHCARE IN PRIVATE HOSPITALS
Aug 11, 2026, 17:15 PM -
REAL-WORLD EQ-5D-5L UTILITY VALUES IN ADULTS WITH TRANSFUSION-DEPENDENT ß-THALASSEMIA USING UK AND FRENCH VALUE SETS
Aug 11, 2026, 17:15 PM -
SPATIAL AND ECONOMIC MODELING FOR MOBILE STROKE UNIT DEPLOYMENT: A TARGETED REVIEW OF GEOSPATIAL COST-EFFECTIVENESS TO INFORM MODELING STRATEGY
Aug 11, 2026, 17:15 PM -
INSIDE CEESP TECHNICAL EXCHANGES: METHODOLOGICAL SIGNALS FROM RECENT FRENCH ECONOMIC ASSESSMENTS
Aug 11, 2026, 17:15 PM -
ASSESSING THE ALIGNMENT BETWEEN ADDED THERAPEUTIC VALUE AND COST-EFFECTIVENESS: AN ANALYSIS OF PORTUGUESE REIMBURSEMENT DECISIONS
Aug 11, 2026, 17:15 PM -
A SYSTEMATIC LITERATURE REVIEW (SLR) AND INDIRECT TREATMENT COMPARISON (ITC) FEASIBILITY ASSESSMENT IN HOMOLOGOUS RECOMBINATION REPAIR (HRR)-DEFICIENT METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (MCSPC)
Aug 11, 2026, 17:15 PM -
EU HTA IN PRACTICE: MEMBER STATE READINESS AND EARLY LESSONS FROM THE FIRST JCA REPORTS
Aug 11, 2026, 17:15 PM -
A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC AND HUMANISTIC BURDEN OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)
Aug 11, 2026, 17:15 PM -
REPORTING POPULATION NORMS AND SOCIOECONOMIC INEQUALITIES IN SELF-REPORTED HEALTH USING EQ-5D-5L: RESULTS FROM MULTICOUNTRY GENERAL POPULATION SURVEYS
Aug 11, 2026, 17:15 PM -
PHARMACEUTICAL TURNOVER BY ANATOMICAL THERAPEUTIC CHEMICAL (ATC) MAIN GROUPS IN ESTONIA BETWEEN 2012 AND 2024: AN ANALYSIS UTILIZING STATE AGENCY OF MEDICINES STATISTICAL YEARBOOK DATA
Aug 11, 2026, 17:15 PM -
VALUE DATA STUDI: A MODULAR HOSPITAL-PHARMACY METHODOLOGY TO QUANTIFY COST SAVINGS FROM CLINICAL TRIAL DRUG MANAGEMENT WITHIN AN INTEGRATED PHARMACEUTICAL DATA ECOSYSTEM
Aug 11, 2026, 17:15 PM -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CYSTIC FIBROSIS IN TURKIYE: A SCOPING REVIEW
Aug 11, 2026, 17:15 PM
